Resources
News

Michael K. Fee to Lead Verrill’s Health Care and Life Sciences Defense Practice

January 22, 2020 Press Releases

(January 22, 2020) – Verrill is pleased to welcome Michael K. Fee to the firm’s Boston office as a Partner in its nationally recognized Health Care & Life Sciences Group and as the leader of Verrill’s health care and life sciences defense practice.

Fee brings extensive experience with internal investigations, the defense of government investigations and enforcement actions, and in handling all types of health care fraud and abuse matters. He is particularly experienced in matters involving academic medical centers, hospitals, physician groups, and other providers, as well as universities, medical device companies, pharmaceutical manufacturers, PBMs, and health insurers. Fee is also experienced in the areas of securities enforcement, the U.S. Foreign Corrupt Practices Act, export and trade regulation, public corruption, and campaign finance law. He has defended numerous cases brought under the U.S. Civil False Claims Act, litigating these cases against the government and private relators successfully in federal district court and the federal courts of appeals. He also uses his defense experience to assist clients with the design and implementation of compliance systems. Fee also represents clients in complex civil litigation.

“The firm is pleased to welcome Michael to our Health Care & Life Sciences Group, which continues its trajectory of growth and expansion. The practice synergies between Michael and our existing team will only serve to strengthen the high quality, high value services we provide to our clients,” stated K.C. Jones, Managing Partner of Verrill.

Most recently, Fee was a partner and member of the White Collar Defense and Investigations Practice Group and the Litigation and Trial Department in Latham & Watkins, LLP’s Boston office. Prior to that, Fee was a partner and Co-Practice Group Leader of the Government Enforcement and White Collar Practice Group in Ropes & Gray, LLP’s Boston office. Earlier in his career, he served as a prosecutor with the Public Integrity Section of the Criminal Division, United States Department of Justice (DOJ) in Washington, D.C., where he investigated and prosecuted public corruption cases. While at the DOJ, he also served as a Special Assistant United States Attorney in the Office of the U.S. Attorney for the Eastern District of Virginia (Alexandria Division) prosecuting various crimes on federal lands, drug offenses, fraud and homicide.

“For years we have known that many of our large institution and company clients seek Michael’s guidance on their most significant government investigations and enforcement matters. We are thrilled to have him join our team,” explained Andrew P. Rusczek, Chair of Verrill’s Health Care & Life Sciences Group. “His deep experience, smarts, and legal savvy will help us further our core goal of providing unsurpassed value to our health care and life sciences clients across the country.”

Fee received his bachelor’s degree from Boston College and earned his law degree from Boston College Law School. Following law school he clerked for the Honorable A. David Mazzone (D. Mass).

Firm Highlights

Publication/Podcast

Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...

Publication/Podcast

Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...

News

Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group. Jeff Smagula brings to Verrill...

Publication/Podcast

HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...

Publication/Podcast

The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...

Publication/Podcast

“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments

Publication/Podcast

Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Publication/Podcast

340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

News

65 Verrill Attorneys Recognized by Best Lawyers® 2022, Including Eight Named Lawyers of the Year

(August 31, 2021) – 65 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2022 , including 8 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer in...

Contact Verrill at (855) 307 0700